These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1605610)

  • 21. The antibacterial activity of ticarcillin/clavulanic acid (BRL28500) against ticarcillin-resistant bacteria.
    Kasai T; Nishino T; Kazuno Y; Tanino T
    J Antibiot (Tokyo); 1986 Oct; 39(10):1450-60. PubMed ID: 3536827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
    Branger C; Kitzis M; Le Mée J
    Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid on human granulocyte activity: a comparative study.
    Cuffini AM; Tullio V; Paizis G; Carlone NA
    J Antimicrob Chemother; 1996 Dec; 38(6):1013-22. PubMed ID: 9023648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1984 Mar; 25(3):392-4. PubMed ID: 6721472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC; Barry AL
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-lactam resistance in Campylobacter coli and Campylobacter jejuni chicken isolates and the association between bla
    Casagrande Proietti P; Guelfi G; Bellucci S; De Luca S; Di Gregorio S; Pieramati C; Franciosini MP
    Vet Microbiol; 2020 Feb; 241():108553. PubMed ID: 31928700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.
    Fuchs PC; Jones RN; Barry AL
    J Clin Microbiol; 1989 Nov; 27(11):2475-81. PubMed ID: 2808671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM; Ueno Y; Cunha BA
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
    Fox PM; Lampen RJ; Stumpf KS; Archer GL; Climo MW
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
    Cantoni L; Wenger A; Glauser MP; Bille J
    J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
    [No Abstract]   [Full Text] [Related]  

  • 37. Bactericidal effects of ticarcillin-clavulanic acid against Legionella pneumophila pneumonia in immunocompromised weanling rats.
    Smith GM; Abbott KH; Wilkinson MJ; Beale AS; Sutherland R
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1423-9. PubMed ID: 1929303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Chambers HF; Sachdeva M; Kennedy S
    J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination.
    Cantoni L; Glauser MP; Bille J
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2348-53. PubMed ID: 1965105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.